Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
July-2016 Volume 38 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2016 Volume 38 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

RbAp48, a novel inhibitory factor that regulates the transcription of human immunodeficiency virus type 1

  • Authors:
    • Juan Wang
    • Jin Yang
    • Zongxing Yang
    • Xiangyun Lu
    • Changzhong Jin
    • Linfang Cheng
    • Nanping Wu
  • View Affiliations / Copyright

    Affiliations: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China , Department of Medicine, Blood Center of Zhejiang Province, Hangzhou, Zhejiang 330100, P.R. China, Xixi Hospital of Hangzhou, Hangzhou, Zhejiang 310023, P.R. China
  • Pages: 267-274
    |
    Published online on: May 19, 2016
       https://doi.org/10.3892/ijmm.2016.2598
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Retinoblastoma binding protein 4 (RbAp48) is a histone chaperone which has been suggested to play a role in gene silencing. However, the role of RbAp48 in human immunodeficiency virus type 1 (HIV-1) infection and gene replication has not been determined to date, to the best of our knowledge. For this purpose, we demonstrated in the present study that RbAp48 expression was upregulated by HIV-1 infection, whereas the knockdown of RbAp48 promoted HIV infection and the production of virus particles. The ectopic expression of RbAp48 inhibited HIV-1 expression, and this inhibition correlated with a marked decrease in the expression of HIV-1 genomic RNA and various RNA transcripts. Further experiments to determine the mechanism responsible for the inhibitory effects of RbAp48 revealed that the ectopic expression of RbAp48 repressed HIV-1 long terminal repeat (LTR)-mediated basal transcription as well as TNF-α- and phorbol 12-myristate 13-acetate (PMA)‑activated transcription. Furthermore, the results of the electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP) analysis revealed that RbAp48 binds to the HIV-1 LTR in vitro. Taken together, these findings demonstrate that, as a transcriptional cofactor, RbAp48 is likely to act as a potent antiretroviral defense.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Mohammadi P, di Iulio J, Muñoz M, Martinez R, Bartha I, Cavassini M, Thorball C, Fellay J, Beerenwinkel N, Ciuffi A and Telenti A: Dynamics of HIV latency and reactivation in a primary CD4+ T cell model. PLoS Pathog. 10:e10041562014. View Article : Google Scholar

2 

Mbonye U and Karn J: Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure. Virology. 454–455:328–339. 2014. View Article : Google Scholar

3 

Maldarelli F, Wu X, Su L, Simonetti FR, Shao W, Hill S, Spindler J, Ferris AL, Mellors JW, Kearney MF, et al: HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science. 345:179–183. 2014. View Article : Google Scholar : PubMed/NCBI

4 

Van Lint C, Bouchat S and Marcello A: HIV-1 transcription and latency: an update. Retrovirology. 10:672013. View Article : Google Scholar : PubMed/NCBI

5 

Qian YW, Wang YCJ, Hollingsworth RE Jr, Jones D, Ling N and Lee EYHP: A retinoblastoma-binding protein related to a negative regulator of Ras in yeast. Nature. 364:648–652. 1993. View Article : Google Scholar : PubMed/NCBI

6 

Zhang W, Tyl M, Ward R, Sobott F, Maman J, Murthy AS, Watson AA, Fedorov O, Bowman A, Owen-Hughes T, et al: Structural plasticity of histones H3-H4 facilitates their allosteric exchange between RbAp48 and ASF1. Nat Struct Mol Biol. 20:29–35. 21022013. View Article : Google Scholar :

7 

Loyola A and Almouzni G: Histone chaperones, a supporting role in the limelight. Biochim Biophys Acta. 1677:3–11. 2004. View Article : Google Scholar : PubMed/NCBI

8 

Allen HF, Wade PA and Kutateladze TG: The NuRD architecture. Cell Mol Life Sci. 70:3513–3524. 2013. View Article : Google Scholar : PubMed/NCBI

9 

Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A and Reinberg D: Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev. 13:1924–1935. 1999. View Article : Google Scholar : PubMed/NCBI

10 

Cismasiu VB, Paskaleva E, Suman Daya S, Canki M, Duus K and Avram D: BCL11B is a general transcriptional repressor of the HIV-1 long terminal repeat in T lymphocytes through recruitment of the NuRD complex. Virology. 380:173–181. 2008. View Article : Google Scholar : PubMed/NCBI

11 

O'Connor MD, Wederell E, Robertson G, Delaney A, Morozova O, Poon SSS, Yap D, Fee J, Zhao Y, McDonald H, et al: Retinoblastoma-binding proteins 4 and 9 are important for human pluripotent stem cell maintenance. Exp Hematol. 39:866–79. e12011. View Article : Google Scholar : PubMed/NCBI

12 

Creekmore AL, Walt KA, Schultz-Norton JR, Ziegler YS, McLeod IX, Yates JR and Nardulli AM: The role of retinoblastoma-associated proteins 46 and 48 in estrogen receptor α mediated gene expression. Mol Cell Endocrinol. 291:79–86. 2008. View Article : Google Scholar : PubMed/NCBI

13 

Ishimaru N, Arakaki R, Yoshida S, Yamada A, Noji S and Hayashi Y: Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjögren's syndrome-like autoimmune exocrinopathy. J Exp Med. 205:2915–2927. 2008. View Article : Google Scholar : PubMed/NCBI

14 

Nicolas E, Morales V, Magnaghi-Jaulin L, Harel-Bellan A, Richard-Foy H and Trouche D: RbAp48 belongs to the histone deacetylase complex that associates with the retinoblastoma protein. J Biol Chem. 275:9797–9804. 2000. View Article : Google Scholar : PubMed/NCBI

15 

Wang J, Lv HJ, Xu L, Yang J, Yang ZX and Wu NP: Generation of human immunodeficiency virus-1 long terminal repeat reporter genes by rapid polymerase chain reaction-nediated mutagenesis. Lab Med. 44:220–227. 2013. View Article : Google Scholar

16 

Liu L, Wang W, Yang L, Ren H, Kimata JT and Zhou P: Trimeric glycosylphosphatidylinositol-anchored HCDR3 of broadly neutralizing antibody PG16 is a potent HIV-1 entry inhibitor. J Virol. 87:1899–1905. 2013. View Article : Google Scholar :

17 

Yang J, Yang Z, Lv H, Lou Y, Wang J and Wu N: Bridging HIV-1 cellular latency and clinical long-term non-progressor: an interactomic view. PLoS One. 8:e557912013. View Article : Google Scholar : PubMed/NCBI

18 

O'Doherty U, Swiggard WJ and Malim MH: Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol. 74:10074–10080. 2000. View Article : Google Scholar : PubMed/NCBI

19 

Nishitsuji H, Abe M, Sawada R and Takaku H: ZBRK1 represses HIV-1 LTR-mediated transcription. FEBS Lett. 586:3562–3568. 2012. View Article : Google Scholar : PubMed/NCBI

20 

Casabianca A, Gori C, Orlandi C, Forbici F, Federico Perno C and Magnani M: Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR green I real-time PCR assay. Mol Cell Probes. 21:368–378. 2007. View Article : Google Scholar : PubMed/NCBI

21 

Jablonski JA and Caputi M: Role of cellular RNA processing factors in human immunodeficiency virus type 1 mRNA metabolism, replication, and infectivity. J Virol. 83:981–992. 2009. View Article : Google Scholar :

22 

Yedavalli VSRK and Jeang KT: Trimethylguanosine capping selectively promotes expression of Rev-dependent HIV-1 RNAs. Proc Natl Acad Sci USA. 107:14787–14792. 2010. View Article : Google Scholar : PubMed/NCBI

23 

Lejon S, Thong SY, Murthy A, AlQarni S, Murzina NV, Blobel GA, Laue ED and Mackay JP: Insights into association of the NuRD complex with FOG-1 from the crystal structure of an RbAp48·FOG-1 complex. J Biol Chem. 286:1196–1203. 2011. View Article : Google Scholar

24 

Lewin SR and Rouzioux C: HIV cure and eradication: how will we get from the laboratory to effective clinical trials? AIDS. 25:885–897. 2011. View Article : Google Scholar : PubMed/NCBI

25 

Gururaja T, Li W, Bernstein J, Payan DG and Anderson DC: Use of MEDUSA-based data analysis and capillary HPLC-ion-trap mass spectrometry to examine complex immunoaffinity extracts of RBAp48. J Proteome Res. 1:253–261. 2002. View Article : Google Scholar

26 

Kumar A, Darcis G, Van Lint C and Herbein G: Epigenetic control of HIV-1 post integration latency: implications for therapy. Clin Epigenetics. 7:1032015. View Article : Google Scholar : PubMed/NCBI

27 

Coull JJ, Romerio F, Sun JM, Volker JL, Galvin KM, Davie JR, Shi Y, Hansen U and Margolis DM: The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. J Virol. 74:6790–6799. 2000. View Article : Google Scholar : PubMed/NCBI

28 

Sreenath K, Pavithra L, Singh S, Sinha S, Dash PK, Siddappa NB, Ranga U, Mitra D and Chattopadhyay S: Nuclear matrix protein SMAR1 represses HIV-1 LTR mediated transcription through chromatin remodeling. Virology. 400:76–85. 2010. View Article : Google Scholar : PubMed/NCBI

29 

Wang XM, Nadeau PE, Lin S, Abbott JR and Mergia A: Caveolin 1 inhibits HIV replication by transcriptional repression mediated through NF-κB. J Virol. 85:5483–5493. 2011. View Article : Google Scholar : PubMed/NCBI

30 

Vemula SV, Veerasamy R, Ragupathy V, Biswas S, Devadas K and Hewlett I: HIV-1 induced nuclear factor I-B (NF-IB) expression negatively regulates HIV-1 replication through interaction with the long terminal repeat region. Viruses. 7:543–558. 2015. View Article : Google Scholar : PubMed/NCBI

31 

Rom S, Reichenbach NL, Dykstra H and Persidsky Y: The dual action of poly(ADP-ribose) polymerase -1 (PARP-1) inhibition in HIV-1 infection: HIV-1 LTR inhibition and diminution in Rho GTPase activity. Front Microbiol. 6:8782015. View Article : Google Scholar : PubMed/NCBI

32 

Kundu M, Srinivasan A, Pomerantz RJ and Khalili K: Evidence that a cell cycle regulator, E2F1, down-regulates transcriptional activity of the human immunodeficiency virus type 1 promoter. J Virol. 69:6940–6946. 1995.PubMed/NCBI

33 

Kundu M, Guermah M, Roeder RG, Amini S and Khalili K: Interaction between cell cycle regulator, E2F-1, and NF-kappaB mediates repression of HIV-1 gene transcription. J Biol Chem. 272:29468–29474. 1997. View Article : Google Scholar : PubMed/NCBI

34 

Williams SA, Chen LF, Kwon H, Ruiz-Jarabo CM, Verdin E and Greene WC: NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J. 25:139–149. 2006. View Article : Google Scholar

35 

Jullien PE, Mosquna A, Ingouff M, Sakata T, Ohad N and Berger F: Retinoblastoma and its binding partner MSI1 control imprinting in Arabidopsis. PLoS Biol. 6:e1942008. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang J, Yang J, Yang Z, Lu X, Jin C, Cheng L and Wu N: RbAp48, a novel inhibitory factor that regulates the transcription of human immunodeficiency virus type 1. Int J Mol Med 38: 267-274, 2016.
APA
Wang, J., Yang, J., Yang, Z., Lu, X., Jin, C., Cheng, L., & Wu, N. (2016). RbAp48, a novel inhibitory factor that regulates the transcription of human immunodeficiency virus type 1. International Journal of Molecular Medicine, 38, 267-274. https://doi.org/10.3892/ijmm.2016.2598
MLA
Wang, J., Yang, J., Yang, Z., Lu, X., Jin, C., Cheng, L., Wu, N."RbAp48, a novel inhibitory factor that regulates the transcription of human immunodeficiency virus type 1". International Journal of Molecular Medicine 38.1 (2016): 267-274.
Chicago
Wang, J., Yang, J., Yang, Z., Lu, X., Jin, C., Cheng, L., Wu, N."RbAp48, a novel inhibitory factor that regulates the transcription of human immunodeficiency virus type 1". International Journal of Molecular Medicine 38, no. 1 (2016): 267-274. https://doi.org/10.3892/ijmm.2016.2598
Copy and paste a formatted citation
x
Spandidos Publications style
Wang J, Yang J, Yang Z, Lu X, Jin C, Cheng L and Wu N: RbAp48, a novel inhibitory factor that regulates the transcription of human immunodeficiency virus type 1. Int J Mol Med 38: 267-274, 2016.
APA
Wang, J., Yang, J., Yang, Z., Lu, X., Jin, C., Cheng, L., & Wu, N. (2016). RbAp48, a novel inhibitory factor that regulates the transcription of human immunodeficiency virus type 1. International Journal of Molecular Medicine, 38, 267-274. https://doi.org/10.3892/ijmm.2016.2598
MLA
Wang, J., Yang, J., Yang, Z., Lu, X., Jin, C., Cheng, L., Wu, N."RbAp48, a novel inhibitory factor that regulates the transcription of human immunodeficiency virus type 1". International Journal of Molecular Medicine 38.1 (2016): 267-274.
Chicago
Wang, J., Yang, J., Yang, Z., Lu, X., Jin, C., Cheng, L., Wu, N."RbAp48, a novel inhibitory factor that regulates the transcription of human immunodeficiency virus type 1". International Journal of Molecular Medicine 38, no. 1 (2016): 267-274. https://doi.org/10.3892/ijmm.2016.2598
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team